Xiaomi targets 100% 5g smartphone portfolio by 2025, holds off electric car launch in India

The US Federal Reserve’s decision to cut rates by 50 basis points is unlikely to prompt an immediate reaction from RBI. This move could help […]

AstraZeneca Pharma India has received approval from the Central Drugs Standard Control Organisation to import Durvalumab for sale and distribution. The drug, combined with chemotherapy, […]

Air India has reduced its losses by 60 per cent to Rs 4,444.10 crore in FY24 compared to Rs 11,387.96 crore in FY23. The airline’s […]